Institutional investors hold a majority ownership of MRK through the 75.24% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2016, these large investors purchased a net $19.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 10.1 Million shares of Merck
UBS ASSET MANAGEMENT (AMERICAS) ... Bought 6.7 Million shares of Merck
THE VANGUARD GROUP, INC. Bought 4.7 Million shares of Merck